Home / Sell by State / California / San Francisco Bay Area
San Francisco Bay Area · Sell-Side M&A
The Bay Area carries the densest verified buyer footprint of any West Coast metro. Three separate private-equity-backed platforms already run clinics here: SkinSpirit, backed by KKR and founded in Palo Alto, LaserAway, backed by Ares Management, and Skin Laundry, backed by Burch Creative Capital. That competition is real, and so is California's strict structure rule. We represent Bay Area owners only, and we build the deal around the rules and the buyers actually operating here.
A confidential ballpark in under two minutes, no email required.
The State Rules, In Brief
California restricts the corporate practice of medicine more tightly than almost any other state, so a non-physician, a private equity firm, or a general corporation cannot own a medical practice or control clinical decisions in the Bay Area. The lawful path is the friendly-PC and MSO model: a physician-owned professional corporation keeps the clinical practice, and a separate management services organization, the part a non-physician investor owns and funds, provides non-clinical business services for a fee. The MSO is what gets bought and sold, which is why a Bay Area sale is a structured transaction, never a simple stock sale. SB 351, effective January 1, 2026, bars private equity groups and hedge funds from controlling clinical matters and bans non-compete and non-disparagement clauses in these management arrangements, so older agreements may need rework before close. AB 1415, also effective January 1, 2026, adds MSOs and PE groups to premerger notice to California's Office of Health Care Affordability for larger deals. There is no San Francisco County rule that overrides this. The same California law governs a deal in San Francisco, Oakland, Palo Alto, or anywhere in the metro. That is the short version, focused on what matters for a Bay Area deal. The full statutory anchors and the deeper compliance treatment live on our California state hub.
| Measure | Figure | Note |
|---|---|---|
| Med spas in California | ~1,150 | Second-largest by count |
| National rank by count | 2nd | Behind FL ~1,180 |
| Out of U.S. total | 10,488 | All U.S. med spas |
| Bay Area positioning | 3 PE platforms | Verified local clinics |
No independently citable med-spa count exists for the Bay Area alone, because city directory scrapes count non-physician day spas and salons and far exceed the state cap, so density is framed at the verified state level. California counts roughly 1,150 medical spas, second nationally out of 10,488. Treat the figures as data-set estimates, not a state-certified statistic.
Market Reality
California counts roughly 1,150 medical spas in a data set drawing on AmSpa's 2024 State of the Medical Spa Industry report and US Census County Business Patterns, ranking it second nationally out of 10,488 med spas in the United States, behind Florida at roughly 1,180. There is no honest metro-level count to quote, because the inflated city directory figures count non-medical spas, so we frame density at the state level and let the buyer record speak. In the Bay Area that record is unusually strong: three PE-backed platforms, SkinSpirit (KKR), LaserAway (Ares), and Skin Laundry (Burch), already run local clinics, and 2026 is shaping up as a potential record year for med-spa M&A. That is the consolidation demand a Bay Area seller is sitting on.
Run my numbers →See Your Number First
A confidential ballpark in under two minutes. No email required to see your range. The estimate is generated on your device. Nothing is stored or sent unless you choose to continue.
Step 1 · Instant ballpark
Estimated enterprise value
Practices like yours trade around 2.6x – 5.3x adjusted earnings.
What raises your number
What lowers your number
Step 2 · What you receive when you continue
Your custom valuation report. Comparable transactions, your likely buyer pool, and timing analysis.
Your buyer-readiness scorecard. The specific moves that raise your multiple before you go to market.
A confidential 30-minute strategy call with Bill Walker. No obligation, no pressure.
Your information is never shared, and we have never broken a client's confidentiality.
Estimate only. A ballpark from limited inputs plus published industry M&A benchmarks.
What Moves Value Here
No San Francisco Bay Area-specific sale multiple is published, and we will not invent one. The honest anchor is the national vertical range already on our med spa, cosmetic dermatology, and plastic surgery hubs. What changes a Bay Area seller's realized value is how the deal has to be built under California structure, and how much buyer competition three already-present PE platforms create. Competition can move you toward the top of the national range. It does not produce a separate Bay Area number.
Because a California deal runs through a friendly-PC and MSO wrap, a buyer is paying for the MSO's management-fee stream and the durability of the PC relationship, not a clean equity purchase. A cleanly structured Bay Area practice transacts faster and holds its multiple.
See the state rules →Three PE-backed platforms already operate clinics in the Bay Area, which means a well-run local practice has more than one credible acquirer to bring to the table. More buyer competition for a prepared seller supports the national range rather than a single take-it-or-leave-it offer.
See who is buying →SB 351 forces management and employment agreements to be cleaned up before close, and AB 1415 notice can add time to larger California transactions, which buyers price in. Getting the structure right before market protects your price through diligence.
Map my structure →We reference the national vertical multiple range published on our practice-type hubs. We do not publish a San Francisco Bay Area-specific multiple, because none exists in a citable, defensible form. In the Bay Area, value is moved more by structure, compliance readiness, and verified buyer competition than by a geographic multiple. Your real range comes from a confidential, practice-specific analysis of your earnings, your MSO structure, and your comps.
Who Is Actually Buying in the San Francisco Bay Area
A Bay Area seller is not waiting on hypothetical demand. Three private-equity-backed aesthetics platforms operate documented clinics inside San Francisco city limits and across the metro, which is an unusually dense verified buyer footprint for a market this size. SkinSpirit, which took a minority investment from KKR in October 2022, was founded in Palo Alto in 2003 and runs two San Francisco clinics, in Noe Valley at 3939 24th Street and in Presidio Heights at 3325 Sacramento Street, plus locations in Oakland and Burlingame. LaserAway, backed by Ares Management since October 2021, runs two San Francisco clinics, in the Marina and in the Castro. Skin Laundry, backed by Burch Creative Capital, operates a clinic at 1870 Union Street. Three funded buyers in one metro is competitive tension a seller can use, and it sets the tone for what a Bay Area owner can take to market.
Detail bars are redacted by design. Every name and activity claim on this board is published from verifiable records; anything beyond the public record stays confidential. SkinSpirit's KKR investment is documented via an October 2022 BusinessWire release, with the Noe Valley and Presidio Heights locations confirmed on the company directory. LaserAway's Ares Management investment is documented via an October 2021 BusinessWire release, with the Marina and Castro locations confirmed on the LaserAway California locations page. Skin Laundry's Union Street location is confirmed via the company locations page and a current Yelp listing, and its Burch Creative Capital backing is documented on the investor's own published portfolio. The national M&A outlook is from the American Med Spa Association's published med spa M&A commentary, which frames a record 2026 as conditional on anticipated recapitalizations. No local-only buyer is invented.
San Francisco Bay Area Sale FAQ
Three private-equity-backed platforms run documented clinics in the Bay Area, which is an unusually dense verified buyer footprint for a market this size. SkinSpirit, which took a minority investment from KKR in October 2022, was founded in Palo Alto in 2003 and operates two San Francisco clinics, in Noe Valley at 3939 24th Street and in Presidio Heights at 3325 Sacramento Street, plus locations in Oakland and Burlingame. LaserAway, backed by Ares Management since October 2021, runs two San Francisco clinics, in the Marina and in the Castro. Skin Laundry, backed by Burch Creative Capital, operates a clinic at 1870 Union Street in San Francisco. These are named, public, in-market operators confirmed through company press releases and locations pages, not national platforms that mention the city in passing. We name them because the footprint is verifiable, and we will never assert a local-only buyer that does not exist.
California is the second-largest med-spa state in the country, and the Bay Area is where the consolidation race is most visible. The metro is the founding home of SkinSpirit, the KKR-backed platform born in Palo Alto, and three separate PE-backed operators now compete for clinic positions inside San Francisco city limits and across the broader Bay Area. That density of capital is the local story. When more than one well-funded buyer already operates in your metro, a seller has real competitive tension to work with, which is exactly the dynamic that supports a stronger process. Paired with California structure, that buyer competition is what a Bay Area seller takes to market.
No. There is no published San Francisco Bay Area-specific multiple, and we will not quote one. What we use is the national vertical range for your practice type, then we explain how California law and the Bay Area market move structure and value. A practice that is already cleanly structured for compliance, with a defensible MSO agreement and no SB 351-offending clauses, transacts faster and holds its value. A practice that is not invites re-trading and discounts. Bay Area buyer competition supports the national range for a well-prepared seller, but it does not create a citable metro multiple. Your real number comes from a confidential, practice-specific analysis.
California restricts the corporate practice of medicine, so a non-physician, a private equity firm, or a general corporation cannot own a medical practice or control clinical decisions in the Bay Area. The lawful path is the friendly-PC and MSO model: a physician-owned professional corporation keeps the clinical practice, and a separate management services organization, the part a non-physician investor owns and funds, contracts to provide non-clinical business services for a fee. The MSO is what gets bought and sold. SB 351, effective January 1, 2026, bars private equity groups and hedge funds from controlling clinical matters and bans non-compete and non-disparagement clauses in these management arrangements. AB 1415, also effective January 1, 2026, adds MSOs, private equity groups, and hedge funds to California’s premerger notice regime under the Office of Health Care Affordability. Because every named Bay Area buyer is PE-backed, these two laws bear directly on how a local deal must be built. For the full statutory treatment, see our California state hub. This page focuses on how those rules play out in the Bay Area deal market.
California counts roughly 1,150 medical spas in a data set drawing on the American Med Spa Association 2024 State of the Medical Spa Industry report and US Census County Business Patterns, ranking it second nationally out of 10,488 med spas in the United States, behind Florida at roughly 1,180. There is no independently citable count of med spas for the Bay Area alone, because directory scrapes that report city figures count non-physician day spas and salons rather than true medical spas, so we frame density at the verified state level. What is verifiable in the Bay Area is the buyer side: three PE-backed platforms already operate local clinics, and a deep national field of PE-backed consolidators is competing for independent practices, with 2026 shaping up as a potential record year for med-spa M&A. Treat the state figures as data-set estimates, not a state-certified statistic.
Yes, unless and until you choose to tell people. We run every process under strict confidentiality, with confidentiality agreements, secure data rooms, staged disclosure, and a vetted buyer process. Premature disclosure can unsettle staff, shake patient confidence, and weaken your negotiating position in a competitive Bay Area market, so you decide what is shared, with whom, and when. Note that under AB 1415, some larger California transactions can require advance notice to the Office of Health Care Affordability, and we plan for that openly with you as part of the structure.
Where To Go Next
The full corporate-practice-of-medicine treatment: the friendly-PC and MSO model, the 2026 SB 351 and AB 1415 reforms, and the statutory anchors that govern every California sale.
Read the California state hub →How recurring and membership revenue, provider capacity, and key-person risk set a med spa's value, paired with the Bay Area buyer competition and California structure work above.
Med spa sell-side →The valuation and deal-structure work for a surgical aesthetic practice, mapped to California's corporate-practice rules and the Bay Area buyer market.
Plastic surgery sell-side →Why the Bay Area Deal Needs Careful Structure
California sets the structure rules, and the full statutory treatment lives on our California state hub. What makes the Bay Area different inside that state is the buyer profile. Every named local operator here is private-equity-backed, and California's two newest laws, both effective January 1, 2026, were written for exactly that kind of buyer. That is the local axis a Bay Area seller has to get right before market.
SB 351 bars private equity groups and hedge funds from controlling clinical matters, from the tests a provider orders to who is hired and fired. Because every named Bay Area buyer is PE-backed, your management agreement has to be clean of these control terms before a deal can close.
AB 1415 adds MSOs, private equity groups, and hedge funds to California's premerger notice regime under the Office of Health Care Affordability. A larger Bay Area transaction can now trigger a notice period, which a PE buyer prices into timeline and terms.
SB 351 also bans non-compete and non-disparagement clauses in these management arrangements. Older agreements written before the law took effect may carry clauses that now have to be reworked, and a buyer will flag them in diligence.
The Medical Board of California, the Board of Registered Nursing, and the Attorney General have pursued paper medical-director arrangements. A Bay Area practice with a genuine physician-owned PC and a real medical director defends its value where a paper structure invites discounts.
Who you work with
Bill Walker founded Aesthetic Brokers after leading mergers and acquisitions for a large private-equity-backed healthcare services organization. Before that he flew for the Marine Corps at the Presidential Helicopter Squadron and commanded a squadron in combat. He knows how an investor values a practice, and how to make sure that value lands with you, not the buyer.
Talk with Bill about your practiceStart with a confidential, two-minute read on where you stand.
